<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05119361</url>
  </required_header>
  <id_info>
    <org_study_id>454</org_study_id>
    <nct_id>NCT05119361</nct_id>
  </id_info>
  <brief_title>Early Dry Cohort : Impact on the Fluid Balance of a Perfusion Based Protocol to Adjust UFnet During Deresuscitation in Intensive Care Unit.</brief_title>
  <acronym>Early Dry</acronym>
  <official_title>Impact on the Fluid Balance of a Perfusion Based Protocol to Adjust UFnet During Deresuscitation in Intensive Care Unit. A Before-after Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid overload is frequent and associated with mortality in critically ill patients,&#xD;
      especially those with acute kidney injury. If fluid loading is a cornerstone of a&#xD;
      resuscitation strategy, some authors promote an evacuation phase to limit the fluid overload&#xD;
      exposure (deresuscitation strategy). In patients with continuous renal therapy, often&#xD;
      presenting an inadequate diuresis, it includes the net ultrafiltration setting. A potential&#xD;
      side effect of deresuscitation strategy is to induce iatrogenic hypovolemia.&#xD;
&#xD;
      We have implemented a perfusion-based protocol to induce systematic early fluid removal on&#xD;
      patients after haemodynamic stabilization. We would like to observe the impact on the fluid&#xD;
      balance of such a protocol and to explore the recruitment capacity of our centre and&#xD;
      exploratory outcomes to lead a future randomized control study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Actual">September 1, 2021</completion_date>
  <primary_completion_date type="Actual">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Computed cumulative fluid balance (mL) at day 5 after protocol onset.</measure>
    <time_frame>Day 5 after protocol onset.</time_frame>
    <description>Cumulative between input and output, defined as follow:&#xD;
Input = cumulative volume of:&#xD;
Medication&#xD;
Enteral and parenteral feeding&#xD;
Fluid loading&#xD;
Transfusion products&#xD;
Output = cumulative volume of:&#xD;
diuresis&#xD;
surgical drainage&#xD;
net ultrafiltration</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>before protocol implementation</arm_group_label>
    <description>A control group reflecting usual practice about net ultrafiltration and deresuscitation strategy in patients with continuous renal replacement therapy in our Department.&#xD;
All patients meeting eligibility criteria between 01/01/2020 and 31/12/2021 will be include.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>after protocol implementation</arm_group_label>
    <description>All patients treated by our deresuscitation protocol between 15/02/2020 and 15/08/2021 will be included.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early Dry protocol</intervention_name>
    <description>After meeting eligibility criteria, patients have a net ultrafiltration of 2mL/kg/h with systematic perfusion monitoring (lactate concentration, central venous saturation, mottling score and capillary refill time) and restrictive input.&#xD;
If the patient presents hypoperfusion (at least to sign), net ultrafiltration is stopped and haemodynamic optimized.&#xD;
If the patient presents pulmonary oedema or right ventricular failure, with venous congestion, ultrafiltration is set at 3mL/kg/h.&#xD;
Ultrafiltration is set between 0.5 and 1mL/kg/h when the following criteria are fulfilled: weight inferior to the admission weight; central venous pressure inferior to 5mmHg; absence of clinical oedema.&#xD;
The haemodynamic status is reevaluated all six hours.</description>
    <arm_group_label>after protocol implementation</arm_group_label>
    <arm_group_label>before protocol implementation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Patients in intensive care unit with acute kidney injury with continuous renal&#xD;
        replacement therapy and fluid overload, with hemodynamic instability&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  - Age ≥ 18 ans&#xD;
&#xD;
          -  Acute kidney injury with continuous renal replacement therapy&#xD;
&#xD;
          -  Fluid overload &gt; 5%&#xD;
&#xD;
          -  Equivalent Norepinephrine dose &lt; 0,5 µg/kg/min&#xD;
&#xD;
          -  Absence of hypoperfusion signs &gt; 12h&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Chronic intermittent haemodialysis&#xD;
&#xD;
          -  Active bleeding&#xD;
&#xD;
          -  Stroke with coma&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital cardiologique Louis Pradel - HCL</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 2, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ultrafiltration</keyword>
  <keyword>deresuscitation</keyword>
  <keyword>fluid overload</keyword>
  <keyword>fluid balance.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

